Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

被引:0
|
作者
Hirvonen, J
van Erp, TGM
Huttunen, J
Någren, K
Huttunen, M
Lönnqvist, J
Kaprio, J
Hietala, J
Cannon, TD
机构
[1] Univ Turku, Dept Pharmacol & Clin Pharmacol, FI-20520 Turku, Finland
[2] Turku Univ, Cent Hosp, Turku PET Ctr, FI-20521 Turku, Finland
[3] Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA
[6] Univ Turku, Dept Psychiat, FI-20520 Turku, Finland
[7] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland
[8] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:97 / 97
页数:1
相关论文
共 50 条
  • [31] History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
    Madras, Bertha K.
    [J]. JOURNAL OF THE HISTORY OF THE NEUROSCIENCES, 2013, 22 (01) : 62 - 78
  • [32] Epigenetic variance in dopamine D2 receptor: a marker of IQ malleability?
    Jakob A. Kaminski
    Florian Schlagenhauf
    Michael Rapp
    Swapnil Awasthi
    Barbara Ruggeri
    Lorenz Deserno
    Tobias Banaschewski
    Arun L. W. Bokde
    Uli Bromberg
    Christian Büchel
    Erin Burke Quinlan
    Sylvane Desrivières
    Herta Flor
    Vincent Frouin
    Hugh Garavan
    Penny Gowland
    Bernd Ittermann
    Jean-Luc Martinot
    Marie-Laure Paillère Martinot
    Frauke Nees
    Dimitri Papadopoulos Orfanos
    Tomáš Paus
    Luise Poustka
    Michael N. Smolka
    Juliane H. Fröhner
    Henrik Walter
    Robert Whelan
    Stephan Ripke
    Gunter Schumann
    Andreas Heinz
    [J]. Translational Psychiatry, 8
  • [33] Increased Striatal Dopamine D2/3 Receptor Availability and its Association with Executive Function in Adults with Phenylketonuria
    Boot, Erik
    Hollak, Carla E.
    Huijbregts, Stephan C.
    Jahja, Rianne
    van Amelsvoort, Therese A. M. J.
    Nederveen, Aart J.
    Bakermans, Adrianus J.
    Nieman, Dorien H.
    Bosch, Annet M.
    van Spronsen, Francjan J.
    Bour, Lo J.
    Booij, Jan
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 91S - 91S
  • [34] The past, present and future role of the dopamine D2 receptor in schizophrenia
    Kapur, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S163 - S164
  • [35] The past, present and future role of the dopamine D2 receptor in Schizophrenia
    Kapur, Shitij
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 5 - 5
  • [36] Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia
    Yasuno, F
    Suhara, T
    Okubo, Y
    Sudo, Y
    Inoue, M
    Ichimiya, T
    Takano, A
    Nakayama, K
    Haildin, C
    Farde, L
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06): : 1016 - 1022
  • [37] Striatal dopamine D2/D3 receptor availability in male smokers
    Yang, YK
    Yao, WJ
    McEvoy, JP
    Chu, CL
    Lee, IH
    Chen, PS
    Yeh, TL
    Chiu, NT
    [J]. PSYCHIATRY RESEARCH-NEUROIMAGING, 2006, 146 (01) : 87 - 90
  • [38] Striatal dopaminergic D2 receptor density: A prognostic marker in schizophrenia?
    Catafau, AM
    Corripio, I
    Perez, V
    Tembl, A
    Martin, JC
    Camacho, V
    Flotats, A
    Estorch, M
    Alvarez, E
    Carrio, I
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1034 - 1034
  • [39] Venturesomeness and PET measures of dopamine D2/D3 receptor availability
    Brown, Amira
    Mandelkern, Mark
    Sumerel, Brittany
    London, Edythe
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [40] Amphetamine-induced Dopamine Release and Dopamine D2/3 Receptor Availability in Obesity
    van de Giessen, E.
    Celik, F.
    Schweitzer, D. H.
    van den Brink, W.
    Booij, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S182 - S182